Novel antimicrobial IV catheter lock solution: Glyceryl Trinitrate complements citrate and ethanol in eradicating biofilm organisms


Intravenous literature: Rosenblatt, J., Reitzel, R., Dvorak, T., Jiang, Y.Y., Hachem, R. and Raad, I.I. (2013) Glyceryl Trinitrate Complements Citrate and Ethanol in Eradicating Biofilm Organisms: A Novel Antimicrobial Catheter Lock Solution. Antimicrobial agents and chemotherapy. May 13th. .


Antimicrobial catheter lock therapy is practiced to prevent lumenal-sourced infections of central venous catheters. Citrate has been clinically used as an anticoagulant in heparin-free catheter locks. Ethanol has also been widely studied as an antimicrobial lock solution component. This study reports on the synergy of glyceryl trinitrate (GTN) with citrate and ethanol in rapidly eradicating Methicillin Resistant Staphylococcus aureus, Methicillin Resistant Staphylococcus epidermidis, Pseudomonas aeruginosa and Candida albicans biofilms in an in vitro model for catheter biofilm colonization. GTN has a long history of intravenous use as a hypotensive agent. It is potentially attractive as a component of a catheter lock solution because its physiologic half-life is quite short and its metabolic pathways are known. A lock containing 7% citrate and 20% ethanol required 0.01% GTN to fully eradicate biofilms of all test organisms within 2 hours in the model. This GTN concentration is below levels where clinically significant hypotensive effects are expected.

Main page


Comments are closed.